Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

590 Articles

Jon C. Ogg | Apr 21, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: GE, IBM, Bristol-Myers, Encana, Halliburton, Rio Tinto, WhiteWave and More

Tuesday's top analyst upgrades, downgrades and initiations include GE, IBM, Bristol-Myers Squibb, Encana, Halliburton, Rio Tinto and WhiteWave Foods.

Lee Jackson | Apr 20, 2015 at 9:10 AM EDT

3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings

In a new report, Cowen analysts have sights set on three major pharmaceutical stocks that they expect to have rising…

Lee Jackson | Apr 7, 2015 at 10:30 AM EDT

4 Big Pharmaceutical Stocks to Buy for the Rest of 2015

SunTrust Robinson Humphrey analysts expect the pharmaceutical industry to outperform in 2015, driven in part by a solid new product…

Lee Jackson | Mar 23, 2015 at 9:05 AM EDT

4 Pharmaceutical Stocks to Buy for Outperformance in 2015

A new research report from the technical team at RBC cites Bristol-Myers Squibb, Eli Lilly, Mylan and Perrigo as stocks…

Lee Jackson | Mar 11, 2015 at 9:40 AM EDT

4 Top Pharmaceutical Stocks to Buy for Market Safety

A new research report from SunTrust Robinson Humphrey is very positive on pharmaceuticals, and the analysts expect the sector to…

Chris Lange | Feb 23, 2015 at 9:15 AM EST

Is Rigel Getting Enough From Bristol-Meyers?

Rigel Pharmaceuticals and Bristol-Myers Squibb announced Monday morning that they have entered into a collaboration agreement.

Lee Jackson | Feb 6, 2015 at 10:10 AM EST

5 Top Credit Suisse Health Care Stock Picks to Buy for 2015

24/7 Wall St. reviewed the new Credit Suisse Top Picks for 2015 report, and here are five of the top…

Lee Jackson | Feb 5, 2015 at 10:00 AM EST

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the…

Lee Jackson | Dec 29, 2014 at 10:05 AM EST

5 Top Pharmaceutical Stock Picks for 2015

In a new research report, the SunTrust Robinson Humphrey team highlights the top pharmaceutical stocks to buy for 2015.

Jon C. Ogg | Nov 13, 2014 at 8:20 AM EST

Top Analyst Upgrades and Downgrades: Applied Materials, Broadcom, Cisco, Genworth, SanDisk and More

Thursday's top analyst upgrades, downgrades and initiations include Applied Materials, Broadcom, Cisco Systems, Genworth Financial and SanDisk.

Jon C. Ogg | Oct 16, 2014 at 8:20 AM EDT

Top Analyst Upgrades and Downgrades: AmEx, Baidu, BofA, Citi, Lululemon, Netflix, Tiffany and More

These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Thursday, October 16, 2014.

Lee Jackson | Oct 2, 2014 at 8:55 AM EDT

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

The data is grim: cancer is increasing. Sales of these top oncology drugs are likely to increase as well.

Lee Jackson | Sep 29, 2014 at 8:30 AM EDT

3 Likely Biotech Buyout Candidates

A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could…

Lee Jackson | Sep 3, 2014 at 10:45 AM EDT

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

A new report from the pharmaceutical team at Credit Suisse highlights four top stocks to buy for the remainder of…

Chris Lange | Aug 21, 2014 at 2:44 PM EDT

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had…

1 … 26 27 28 29 30 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top Analyst Upgrades and Downgrades: GE, IBM, Bristol-Myers, Encana, Halliburton, Rio Tinto, WhiteWave and More

3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings

4 Big Pharmaceutical Stocks to Buy for the Rest of 2015

4 Pharmaceutical Stocks to Buy for Outperformance in 2015

4 Top Pharmaceutical Stocks to Buy for Market Safety

Is Rigel Getting Enough From Bristol-Meyers?

5 Top Credit Suisse Health Care Stock Picks to Buy for 2015

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

5 Top Pharmaceutical Stock Picks for 2015

Top Analyst Upgrades and Downgrades: Applied Materials, Broadcom, Cisco, Genworth, SanDisk and More

Top Analyst Upgrades and Downgrades: AmEx, Baidu, BofA, Citi, Lululemon, Netflix, Tiffany and More

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

3 Likely Biotech Buyout Candidates

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top Analyst Upgrades and Downgrades: GE, IBM, Bristol-Myers, Encana, Halliburton, Rio Tinto, WhiteWave and More

3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings

4 Big Pharmaceutical Stocks to Buy for the Rest of 2015

4 Pharmaceutical Stocks to Buy for Outperformance in 2015

4 Top Pharmaceutical Stocks to Buy for Market Safety

Is Rigel Getting Enough From Bristol-Meyers?

5 Top Credit Suisse Health Care Stock Picks to Buy for 2015

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

5 Top Pharmaceutical Stock Picks for 2015

Top Analyst Upgrades and Downgrades: Applied Materials, Broadcom, Cisco, Genworth, SanDisk and More

Top Analyst Upgrades and Downgrades: AmEx, Baidu, BofA, Citi, Lululemon, Netflix, Tiffany and More

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

3 Likely Biotech Buyout Candidates

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

Featured Reads

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)